Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm

2013 ◽  
Vol 164 (2) ◽  
pp. 245-246 ◽  
Author(s):  
Gen-Min Lin ◽  
Yi-Hwei Li ◽  
Lamin .E.S. Jaiteh ◽  
Chih-Lu Han
2019 ◽  
Vol 109 (3) ◽  
pp. 331-338 ◽  
Author(s):  
Bernadet T. Santema ◽  
Michelle M. Y. Chan ◽  
Jasper Tromp ◽  
Martin Dokter ◽  
Haye H. van der Wal ◽  
...  

Abstract Background In heart failure (HF), levels of NT-proBNP are influenced by the presence of concomitant atrial fibrillation (AF), making it difficult to distinguish between HF versus AF in patients with raised NT-proBNP. It is unknown whether levels of GDF-15 are also influenced by AF in patients with HF. In this study we compared the plasma levels of NT-proBNP versus GDF-15 in patients with HF in AF versus sinus rhythm (SR). Methods In a post hoc analysis of the index cohort of BIOSTAT-CHF (n = 2516), we studied patients with HF categorized into three groups: (1) AF at baseline (n = 733), (2) SR at baseline with a history of AF (n = 183), and (3) SR at baseline and no history of AF (n = 1025). The findings were validated in the validation cohort of BIOSTAT-CHF (n = 1738). Results Plasma NT-proBNP levels of patients who had AF at baseline were higher than those of patients in SR (both with and without a history of AF), even after multivariable adjustment (3417 [25th–75th percentile 1897–6486] versus 1788 [682–3870], adjusted p < 0.001, versus 2231 pg/mL [902–5270], adjusted p < 0.001). In contrast, after adjusting for clinical confounders, the levels of GDF-15 were comparable between the three groups (3179 [2062–5253] versus 2545 [1686–4337], adjusted p = 0.36, versus 2294 [1471–3855] pg/mL, adjusted p = 0.08). Similar patterns of both NT-proBNP and GDF-15 were found in the validation cohort. Conclusion These data show that in patients with HF, NT-proBNP is significantly influenced by underlying AF at time of measurement and not by previous episodes of AF, whereas the levels of GDF-15 are not influenced by the presence of AF. Therefore, GDF-15 might have additive value combined with NT-proBNP in the assessment of patients with HF and concomitant AF. Graphic abstract


2013 ◽  
Vol 62 (18) ◽  
pp. C102
Author(s):  
Güliz Kozdağ ◽  
Ender Emre ◽  
Gokhan Ertas ◽  
Yasar Akay ◽  
Irem Yilmaz ◽  
...  

2019 ◽  
Vol 74 (3) ◽  
pp. 235-244 ◽  
Author(s):  
Tomoko Machino-Ohtsuka ◽  
Yoshihiro Seo ◽  
Tomoko Ishizu ◽  
Masayoshi Yamamoto ◽  
Yoshie Hamada-Harimura ◽  
...  

2018 ◽  
Vol 39 (43) ◽  
pp. 3867-3875 ◽  
Author(s):  
Bernadet T Santema ◽  
Mariëlle Kloosterman ◽  
Isabelle C Van Gelder ◽  
Ify Mordi ◽  
Chim C Lang ◽  
...  

Circulation ◽  
1998 ◽  
Vol 98 (23) ◽  
pp. 2574-2579 ◽  
Author(s):  
Prakash C. Deedwania ◽  
Bramah N. Singh ◽  
Kenneth Ellenbogen ◽  
Susan Fisher ◽  
Ross Fletcher ◽  
...  

2018 ◽  
Vol 271 ◽  
pp. 174-180 ◽  
Author(s):  
Luis Alberto Escobar-Robledo ◽  
Antoni Bayés-de-Luna ◽  
Josep Lupón ◽  
Adrian Baranchuk ◽  
Pedro Moliner ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
C Hjalmarsson ◽  
M Fu ◽  
T Zverkova-Sandstrom ◽  
M Schaufelberger ◽  
C Ljungman ◽  
...  

Abstract Background Prediction of ischemic cerebral events in patients with heart failure (HF) in the absence of atrial fibrillation (AF) is challenging. Purpose To prospectively test a staged approach to identify patients with HF and sinus rhythm who are at high risk of developing TIA/ischemic stroke (TIA/IS) during the first two years after diagnosis. Methods The analysis is based on patient data reported in the Swedish Heart Failure Register from January 2003 until December 2013. Patients with AF and those treated with anticoagulants were excluded. The study population was categorized in two groups according to left ventricular ejection fraction: LVEF ≤40% and LVEF >40%. Factors associated with TIA/IS were determined by univariate proportional hazard regression. The risk score included: age (1p for 65–74y; 2p for 75–84y; 3p for ≥85y), previous ischemic heart disease (1p), hypertension (1p), diabetes mellitus (1p), TIA/IS (2p), and kidney dysfunction (1p). Two-year hazard ratios with death as competing risk were computed. The probability of observing the outcome was calculated using the cumulative incidence function. Results A total of 16,865 patients (mean age 72.1±13.2y) were included in the study, 39.9% women; 59.7% had LVEF ≤40%. The two-year crude rate of TIA/IS, hemorrhagic stroke, and all-cause mortality were 3.3%, 0.3%, and 26%, respectively. An incremental absolute risk for TIA/IS was observed for patients with LVEF ≤40% and score 1- ≥6: 1.6, 2.3, 3.6, 2.9, 6.3, and 7.1%, respectively. The corresponding HRs with 95% confidence interval (CI) and the patients with 0 points as reference group were: 2.8 (1.1–7.3), 4.0 (1.6–10.1), 6.6 (2.7–16.2), 5.5 (2.2–13.8), 14.4 (5.8–35.9) for score 1- ≥6, where all p-values were less than 0.05 and Wald χ2 for overall model fit <0.0001. The cumulative incidence per 1000 person-years was: 8.2 (5.4–12.5), 11.8 (8.3–16.7), 19.4 (15.1–24.8), 16.3 (12.6–21.1), 36.6 (29.4–45.4), and 42.1 (33.0–53.8), respectively. In patients with LVEF >40% and score 1–≥6, the absolute TIA/IS risk was: 1.3, 3.1, 3.1, 3.3, 4.6, and 5.3%, respectively. The corresponding HRs with 95% CI and patients with 1 point as reference group was: 2.4 (1.1–5.2), 2.5 (1.2–5.3), 2.7 (1.3–5.7), 3.9 (1.8–8.2); and 4.6 (2.2–9.8), for score 1- ≥6 (all p<0.05 and Wald χ2 for overall model fit p=0.0002). The cumulative incidence per 1000 person-year was: 6.7 (3.4–13.2), 16.0 (10.8–23.8), 16.7 (12.5–22.2), 18.0 (13.9–23.4), 25.8 (19.4–34.3), and 30.6 (21.7–43.0), for score 1- ≥6, respectively. Conclusion In the current study, a risk score compiling age and specific comorbidity was shown to predict increased risk of TIA/IS, regardless of LVEF, during the first two years after diagnosis in patients with incident HF in sinus rhythm.


2016 ◽  
Vol 209 ◽  
pp. 1-6 ◽  
Author(s):  
Line Melgaard ◽  
Anders Gorst-Rasmussen ◽  
Peter Søgaard ◽  
Lars Hvilsted Rasmussen ◽  
Gregory Y.H. Lip ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document